These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4520390)

  • 21. Differences in the binding of drugs to plasma proteins from newborn and adult man. I.
    Kurz H; Mauser-Ganshorn A; Stickel HH
    Eur J Clin Pharmacol; 1977 Jul; 11(6):463-7. PubMed ID: 891592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of renal transplantation on plasma protein binding.
    Affrime MB; Blecker DL; Lyons PJ; Pitone JM; Swartz CD; Lowenthal DT
    J Dial; 1979; 3(2-3):207-18. PubMed ID: 389974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproate plasma protein binding in the uremic condition.
    Brewster D; Muir NC
    Clin Pharmacol Ther; 1980 Jan; 27(1):76-82. PubMed ID: 6985855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of plasma concentration determinations: phenytoin.
    Adler DS
    Clin Toxicol; 1979; 14(2):147-50. PubMed ID: 436388
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of total drug concentration on the free fraction in uremic sera.
    Tiula E; Neuvonen PJ
    Ther Drug Monit; 1986; 8(1):27-31. PubMed ID: 3961893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinidine elimination in patients with congestive heart failure or poor renal function.
    Kessler KM; Lowenthal DT; Warner H; Gibson T; Briggs W; Reidenberg MM
    N Engl J Med; 1974 Mar; 290(13):706-9. PubMed ID: 4813743
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of in vitro and in vivo solute-protein binding interactions in normal and uremic subjects.
    Farrell PC; Grib NL; Fry DL; Popovich RP; Broviac JW; Babb AL
    Trans Am Soc Artif Intern Organs; 1972; 18(0):268-76, 281. PubMed ID: 4679879
    [No Abstract]   [Full Text] [Related]  

  • 28. Decreased plasma protein binding of diazoxide in uremia.
    O'Malley K; Velasco M; Pruitt A; McNay JL
    Clin Pharmacol Ther; 1975 Jul; 18(1):53-8. PubMed ID: 1149362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of radiochemical purity of radiolabeled drugs used for determining plasma protein binding of drugs.
    Bjornsson TD; Brown JE; Tschanz C
    J Pharm Sci; 1981 Dec; 70(12):1372-3. PubMed ID: 7320856
    [No Abstract]   [Full Text] [Related]  

  • 30. Study of serum proteins in health and in ascites of varying etiology.
    Sikka KK; Nath K; Agarwal SN; Gahlaut DS; Mishra SD; Kuchhal PK
    J Assoc Physicians India; 1967 Dec; 15(12):591-4. PubMed ID: 5587369
    [No Abstract]   [Full Text] [Related]  

  • 31. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in plasma protein binding of drugs after blood collection from pregnant rats.
    Chou RC; Levy G
    J Pharm Sci; 1982 Apr; 71(4):471-3. PubMed ID: 7086665
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased plasma protein binding of propranolol in rabbits with acute renal failure.
    Fichtl B; Gerdsmeier W
    Life Sci; 1981 Jan; 28(1):31-5. PubMed ID: 7219042
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased plasma binding of quinidine after surgery: a preliminary report.
    Fremstad D; Bergerud K; Haffner JF; Lunde PK
    Eur J Clin Pharmacol; 1976; 10(6):441-4. PubMed ID: 63371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of acute renal failure on the protein binding of drugs in animals and in man.
    Belpaire FM; Bogaert MG; Mussche MM
    Eur J Clin Pharmacol; 1977; 11(1):27-32. PubMed ID: 832654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered protein binding of diphenylhydantoin in uremic plasma.
    Blum MR; Riegelman S; Becker CE
    N Engl J Med; 1972 Jan; 286(2):109. PubMed ID: 5006870
    [No Abstract]   [Full Text] [Related]  

  • 37. Ultrafiltration vs equilibrium dialysis for determination of free fraction.
    Bowers WF; Fulton S; Thompson J
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():49-60. PubMed ID: 6705427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the erythrocyte partitioning method with two classical methods for estimating free drug fraction in plasma.
    Trung AH; Sirois G; Dubé LM; McGilveray IJ
    Biopharm Drug Dispos; 1984; 5(3):281-90. PubMed ID: 6487754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythrocyte uptake and plasma binding of diphenylhydantoin.
    Kurata D; Wilkinson GR
    Clin Pharmacol Ther; 1974 Aug; 16(2):355-62. PubMed ID: 4851901
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors influencing the apparent protein binding of quinidine.
    Guentert TW; Oie S
    J Pharm Sci; 1982 Mar; 71(3):325-8. PubMed ID: 7069591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.